title: Molecular cloning, refined chromosomal mapping and structural analysis of the human gene encoding aldehyde oxidase (AOX1), a candidate for the ALS2 gene.
abstract: Aldehyde oxidase (AOX) is a member of the xanthine oxidase (XO) family of molybdenum hydroxylase, iron-sulfur flavoproteins and is involved in the metabolism of a wide range of native and xenobiotic compounds. The potentially toxic reduced oxygen intermediates (ROI), hydrogen peroxide (H2O2) and superoxide anion (O2(.-)), are generated when reduced AOX becomes oxidized by molecular oxygen, raising the possibility for involvement of AOX in pathophysiology. Indeed, ROI generation by AOX has been directly implicated in hepatic ethanol toxicity. A cDNA encoding human AOX has been cloned, sequenced, and identified as AOX1. AOX1 was proposed as a candidate for an autosomal recessive form of amyotrophic lateral sclerosis (ALS2) because a YAC carrying AOX1 was mapped to the ALS2 locus and was expressed in microglial cells of the spinal cord. As a source of H2O2, AOX could mediate motor neuron degeneration. To provide a basis for further analysis of AOX1 in pathophysiology, and to examine the relationship of the human AOX1 gene to the gene for human xanthine dehydrogenase (XDH), we have studied the chromosomal locus encoding AOX1 in humans. In the present communication, we have analyzed P1 artificial chromosomes containing AOX1. Our refined chromosomal mapping by FISH locates AOX1 very centromere proximal in the 2q33 region at 2q32.3-2q33.1. We present the first complete structural map of an AOX gene and provide direct evidence that human XDH and AOX1 are related by a gene duplication event. In addition, 1500 bp of upstream DNA containing the putative AOX1 promoter were sequenced and expressed. In contrast to the amino acid coding regions, AOX1 and XDH promoter sequences exhibit marked divergence that reflects the differential activation of these closely related genes. Evidence is presented that AOX may be polygenic in humans as it is in plants, Dipterans, and mice.
authors.affiliation: a Webb-Waring Institute for Biomedical Research , Denver , CO , USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Wright
authors.affiliation: a Webb-Waring Institute for Biomedical Research , Denver , CO , USA.
authors.forename: L K
authors.initials: LK
authors.lastname: Weigel
authors.affiliation: b Department of Medicine, Division of Medical Oncology , Denver , CO , USA.|c The Cancer Center Cytogenetics Core , University of Colorado Health Sciences Center , Denver , CO , USA.
authors.forename: M
authors.initials: M
authors.lastname: Varella-Garcia
authors.affiliation: a Webb-Waring Institute for Biomedical Research , Denver , CO , USA.
authors.forename: G
authors.initials: G
authors.lastname: Vaitaitis
authors.affiliation: a Webb-Waring Institute for Biomedical Research , Denver , CO , USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Repine